| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Carcinogenesis |
Cancer Research Center, The Burnham Institute, La Jolla, California 92037
NG2 is the rat homologue of the human melanoma proteoglycan, also known as the high molecular weight melanoma-associated antigen. This developmentally regulated membrane-spanning chondroitin sulfate proteoglycan is expressed primarily by glial, muscle, and cartilage progenitor cells. Upon maturation, these cell types down-regulate NG2 expression. In adult animals, the expression of NG2 is restricted to tumor cells and angiogenic tumor vasculature, making this proteoglycan a potential target for directing therapeutic agents to relevant sites of action. To this end, we have identified specific NG2-binding peptides by screening a phage-displayed random peptide library on purified NG2. Several rounds of biopanning on NG2 resulted in the specific enrichment of two phage-displayed decapeptides, TAASGVRSMH and LTLRWVGLMS. The binding of these phages to NG2 was inhibitable both by soluble NG2 and by glutathione S-transferase (GST) fusion proteins containing the cognate peptide sequences. In addition, direct binding between GST-TAASGVRSMH and GST-LTLRWVGLMS fusion proteins and NG2 was demonstrated in solid-phase binding assays. Interestingly, these NG2-binding fusion proteins cross-inhibited each others binding to NG2, suggesting that the two sequences bind to the same or overlapping sites on the proteoglycan. Upon injection into tumor-bearing mice, NG2-binding phages specifically homed to tumor vasculature in wild-type mice but did not localize to the tumor vasculature in NG2 knockout mice. The in vivo targeting capability of these sequences suggests that they can be used for tumor targeting.
This article has been cited by other articles:
![]() |
J. Lahdenranta, R. L. Sidman, R. Pasqualini, and W. Arap Treatment of hypoxia-induced retinopathy with targeted proapoptotic peptidomimetic in a mouse model of disease FASEB J, October 1, 2007; 21(12): 3272 - 3278. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Arbiser, T. Kau, M. Konar, K. Narra, R. Ramchandran, S. A. Summers, C. J. Vlahos, K. Ye, B. N. Perry, W. Matter, et al. Solenopsin, the alkaloidal component of the fire ant (Solenopsis invicta), is a naturally occurring inhibitor of phosphatidylinositol-3-kinase signaling and angiogenesis Blood, January 15, 2007; 109(2): 560 - 565. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Oh, I. Mohiuddin, Y. Sun, J. B. Putnam Jr, W. K. Hong, W. Arap, and R. Pasqualini Phenotypic Diversity of the Lung Vasculature in Experimental Models of Metastases Chest, December 1, 2005; 128(6_suppl): 596S - 600S. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Oh, I. Mohiuddin, Y. Sun, J. B. Putnam Jr, W. K. Hong, W. Arap, and R. Pasqualini Phenotypic Diversity of the Lung Vasculature in Experimental Models of Metastases Chest, December 1, 2005; 128(6_suppl): 596S - 600S. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kessler, R. Bieker, T. Padro, C. Schwoppe, T. Persigehl, C. Bremer, M. Kreuter, W. E. Berdel, and R. M. Mesters Inhibition of Tumor Growth by RGD Peptide-Directed Delivery of Truncated Tissue Factor to the Tumor Vasculature Clin. Cancer Res., September 1, 2005; 11(17): 6317 - 6324. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Zitzmann, W. Mier, A. Schad, R. Kinscherf, V. Askoxylakis, S. Kramer, A. Altmann, M. Eisenhut, and U. Haberkorn A New Prostate Carcinoma Binding Peptide (DUP-1) for Tumor Imaging and Therapy Clin. Cancer Res., January 1, 2005; 11(1): 139 - 146. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Hughes and T. Chan-Ling Characterization of Smooth Muscle Cell and Pericyte Differentiation in the Rat Retina In Vivo Invest. Ophthalmol. Vis. Sci., August 1, 2004; 45(8): 2795 - 2806. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y Li, M C Madigan, K Lai, R M Conway, F A Billson, R Crouch, and B J Allen Human uveal melanoma expresses NG2 immunoreactivity Br. J. Ophthalmol., May 1, 2003; 87(5): 629 - 632. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Nakamura, K. Sato, and H. Hamada Reduction of Natural Adenovirus Tropism to the Liver by both Ablation of Fiber-Coxsackievirus and Adenovirus Receptor Interaction and Use of Replaceable Short Fiber J. Virol., February 15, 2003; 77(4): 2512 - 2521. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Sevigny, C. Sundberg, N. Braun, O. Guckelberger, E. Csizmadia, I. Qawi, M. Imai, H. Zimmermann, and S. C. Robson Differential catalytic properties and vascular topography of murine nucleoside triphosphate diphosphohydrolase 1 (NTPDase1) and NTPDase2 have implications for thromboregulation Blood, April 15, 2002; 99(8): 2801 - 2809. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. B. Stallcup and K. Dahlin-Huppe Chondroitin sulfate and cytoplasmic domain-dependent membrane targeting of the NG2 proteoglycan promotes retraction fiber formation and cell polarization J. Cell Sci., March 8, 2002; 114(12): 2315 - 2325. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Essler and E. Ruoslahti Molecular specialization of breast vasculature: A breast-homing phage-displayed peptide binds to aminopeptidase P in breast vasculature PNAS, February 19, 2002; 99(4): 2252 - 2257. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Sundberg, J. A. Nagy, L. F. Brown, D. Feng, I. A. Eckelhoefer, E. J. Manseau, A. M. Dvorak, and H. F. Dvorak Glomeruloid Microvascular Proliferation Follows Adenoviral Vascular Permeability Factor/Vascular Endothelial Growth Factor-164 Gene Delivery Am. J. Pathol., March 1, 2001; 158(3): 1145 - 1160. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Pasqualini, E. Koivunen, R. Kain, J. Lahdenranta, M. Sakamoto, A. Stryhn, R. A. Ashmun, L. H. Shapiro, W. Arap, and E. Ruoslahti Aminopeptidase N Is a Receptor for Tumor-homing Peptides and a Target for Inhibiting Angiogenesis Cancer Res., February 1, 2000; 60(3): 722 - 727. [Abstract] [Full Text] |
||||
![]() |
L. Goretzki, C. R. Lombardo, and W. B. Stallcup Binding of the NG2 Proteoglycan to Kringle Domains Modulates the Functional Properties of Angiostatin and Plasmin(ogen) J. Biol. Chem., September 8, 2000; 275(37): 28625 - 28633. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |